1
|
Jung T, Findik N, Hartmann B, Hanack K, Grossmann K, Roggenbuck D, Wegmann M, Mantke R, Deckert M, Grune T. Automated determination of 8-OHdG in cells and tissue via immunofluorescence using a specially created antibody. BIOTECHNOLOGY REPORTS (AMSTERDAM, NETHERLANDS) 2024; 42:e00833. [PMID: 38948353 PMCID: PMC11211097 DOI: 10.1016/j.btre.2024.e00833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 02/27/2024] [Accepted: 02/27/2024] [Indexed: 07/02/2024]
Abstract
Despite powerful DNA repair systems, oxidative damage/modification to DNA is an inevitable side effect of metabolism, ionizing radiation, lifestyle habits, inflammatory pathologies such as type-2 diabetes or metabolic syndrome, cancer and natural aging. One of the most common oxidative DNA modifications is 8-OHdG (8‑hydroxy-2'-deoxyguanosine), which is the most widely used marker in research and clinical diagnostics. 8-OHdG is easily and specifically detectable in various samples such as urine, plasma, cells and tissues via a large variety of methods like ELISA, HPLC, chromatographic methods, and immunochemistry. Formed by oxidation of guanine and being representative for the degree of DNA damage, 8-OHdG can be also used as biomarker for risk assessment of various cancers as well as degenerative diseases. Here, we present a highly specific, self-developed 8-OHdG antibody in successful comparison to a commercially one, tested in cells (FF95, HCT116, and HT22) and intestinal tissue, focusing on automatized evaluation via fluorescence/confocal microscopy.
Collapse
Affiliation(s)
- Tobias Jung
- Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Arthur-Scheunert-Allee 114-116 14558, Nuthetal, Germany
- German Center for Cardiovascular Research (DZHK), 10117, Berlin, Germany
| | - Nicole Findik
- new/era/mabs GmbH, August-Bebel-Str. 89 14482 Potsdam, Germany
| | - Bianca Hartmann
- new/era/mabs GmbH, August-Bebel-Str. 89 14482 Potsdam, Germany
| | - Katja Hanack
- new/era/mabs GmbH, August-Bebel-Str. 89 14482 Potsdam, Germany
- University of Potsdam, Department of Biochemistry and Biology, Chair of Immunotechnology, Karl-Liebknecht-Str. 24-25, Build 29, Office 1.55 14476 Potsdam, Germany
| | | | - Dirk Roggenbuck
- Faculty of Health Sciences Brandenburg, Brandenburg Technical University Cottbus-Senftenberg
| | - Marc Wegmann
- MEDIPAN GmbH, Ludwig-Erhard-Ring 3 15827 Dahlewitz
| | - René Mantke
- Brandenburg Medical School Theodor Fontane, Klinik für Allgemein- und Viszeralchirurgie, Klinikum Brandenburg, Hochstraße 29 14770 Brandenburg an der Havel, Germany
| | - Markus Deckert
- Brandenburg Medical School Theodor Fontane, Theodor Fontane Campus Brandenburg, Hämatologie, Onkologie SKB, IAG Psychoonkologie und Palliativversorgung, Hochstraße 29, 14770 Brandenburg an der Havel, Germany
| | - Tilman Grune
- Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Arthur-Scheunert-Allee 114-116 14558, Nuthetal, Germany
- German Center for Cardiovascular Research (DZHK), 10117, Berlin, Germany
- German Center for Diabetes Research (DZD) 85764 Muenchen-Neuherberg, Germany
- NutriAct – Competence Cluster Nutrition Research Berlin-Potsdam, 14558 Nuthetal, Germany
- University of Potsdam, Institute of Nutrition 14558 Nuthetal, Germany
| |
Collapse
|
2
|
Schlör A, Holzlöhner P, Listek M, Grieß C, Butze M, Micheel B, Hentschel C, Sowa M, Roggenbuck D, Schierack P, Füner J, Schliebs E, Goihl A, Reinhold D, Hanack K. Generation and validation of murine monoclonal and camelid recombinant single domain antibodies specific for human pancreatic glycoprotein 2. N Biotechnol 2018; 45:60-68. [DOI: 10.1016/j.nbt.2018.03.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2017] [Revised: 02/28/2018] [Accepted: 03/29/2018] [Indexed: 12/24/2022]
|
3
|
Roggenbuck D, Goihl A, Hanack K, Holzlöhner P, Hentschel C, Veiczi M, Schierack P, Reinhold D, Schulz HU. Serological diagnosis and prognosis of severe acute pancreatitis by analysis of serum glycoprotein 2. Clin Chem Lab Med 2017; 55:854-864. [PMID: 27837595 DOI: 10.1515/cclm-2016-0797] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2016] [Accepted: 10/10/2016] [Indexed: 12/12/2022]
Abstract
BACKGROUND Glycoprotein 2 (GP2), the pancreatic major zymogen granule membrane glycoprotein, was reported to be elevated in acute pancreatitis in animal models. METHODS Enzyme-linked immunosorbent assays (ELISAs) were developed to evaluate human glycoprotein 2 isoform alpha (GP2a) and total GP2 (GP2t) as specific markers for acute pancreatitis in sera of 153 patients with acute pancreatitis, 26 with chronic pancreatitis, 125 with pancreatic neoplasms, 324 with non-pancreatic neoplasms, 109 patients with liver/biliary disease, 67 with gastrointestinal disease, and 101 healthy subjects. GP2a and GP2t levels were correlated with procalcitonin and C-reactive protein in 152 and 146 follow-up samples of acute pancreatitis patients, respectively. RESULTS The GP2a ELISA revealed a significantly higher assay accuracy in contrast to the GP2t assay (sensitivity ≤3 disease days: 91.7%, specificity: 96.7%, positive likelihood ratio [LR+]: 24.6, LR-: 0.09). GP2a and GP2t levels as well as prevalences were significantly elevated in early acute pancreatitis (≤3 disease days) compared to all control cohorts (p<0.05, respectively). GP2a and GP2t levels were significantly higher in patients with severe acute pancreatitis at admission compared with mild cases (p<0.05, respectively). Odds ratio for GP2a regarding mild vs. severe acute pancreatitis with lethal outcome was 7.8 on admission (p=0.0222). GP2a and GP2t levels were significantly correlated with procalcitonin [Spearman's rank coefficient of correlation (ρ)=0.21, 0.26; p=0.0110, 0.0012; respectively] and C-reactive protein (ρ=0.37, 0.40; p<0.0001; respectively). CONCLUSIONS Serum GP2a is a specific marker of acute pancreatitis and analysis of GP2a can aid in the differential diagnosis of acute upper abdominal pain and prognosis of severe acute pancreatitis.
Collapse
Affiliation(s)
- Dirk Roggenbuck
- Institute of Biotechnology, Faculty of Environment and Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg
| | - Alexander Goihl
- Institute of Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg
| | - Katja Hanack
- Chair of Immunotechnology, Department of Biochemistry and Biology, University of Potsdam, Potsdam
| | - Pamela Holzlöhner
- Chair of Immunotechnology, Department of Biochemistry and Biology, University of Potsdam, Potsdam
| | | | | | - Peter Schierack
- Institute of Biotechnology, Faculty of Environment and Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg
| | - Dirk Reinhold
- Institute of Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg
| | | |
Collapse
|
4
|
Holzlöhner P, Hanack K. Generation of Murine Monoclonal Antibodies by Hybridoma Technology. J Vis Exp 2017. [PMID: 28117810 DOI: 10.3791/54832] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Abstract
Monoclonal antibodies are universal binding molecules and are widely used in biomedicine and research. Nevertheless, the generation of these binding molecules is time-consuming and laborious due to the complicated handling and lack of alternatives. The aim of this protocol is to provide one standard method for the generation of monoclonal antibodies using hybridoma technology. This technology combines two steps. Step 1 is an appropriate immunization of the animal and step 2 is the fusion of B lymphocytes with immortal myeloma cells in order to generate hybrids possessing both parental functions, such as the production of antibody molecules and immortality. The generated hybridoma cells were then recloned and diluted to obtain stable monoclonal cell cultures secreting the desired monoclonal antibody in the culture supernatant. The supernatants were tested in enzyme-linked immunosorbent assays (ELISA) for antigen specificity. After the selection of appropriate cell clones, the cells were transferred to mass cultivation in order to produce the desired antibody molecule in large amounts. The purification of the antibodies is routinely performed by affinity chromatography. After purification, the antibody molecule can be characterized and validated for the final test application. The whole process takes 8 to 12 months of development, and there is a high risk that the antibody will not work in the desired test system.
Collapse
Affiliation(s)
| | - Katja Hanack
- Department of Biochemistry and Biology, University of Potsdam;
| |
Collapse
|
5
|
Lütkecosmann S, Warsinke A, Tschöpe W, Eichler R, Hanack K. A novel monoclonal antibody suitable for the detection of leukotriene B4. Biochem Biophys Res Commun 2016; 482:1054-1059. [PMID: 27913298 DOI: 10.1016/j.bbrc.2016.11.157] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2016] [Accepted: 11/28/2016] [Indexed: 12/20/2022]
Abstract
Leukotriene B4 as an inflammatory mediator is an important biomarker for different respiratory diseases like asthma, chronic obstructive pulmonary disease or cystic lung fibrosis. Therefore the detection of LTB4 is helpful in the diagnosis of these pulmonary diseases. However, until now its determination in exhaled breath condensates suffers from problems of accuracy. Reasons for that could be improper sample collection and preparation methods of condensates and the lack of consistently assay specificity and reproducibility of the used immunoassay detection system. In this study we describe the development and the characterization of a specific monoclonal antibody (S27BC6) against LTB4, its use as molecular recognition element for the development of an enzyme-linked immunoassay to detect LTB4 and discuss possible future diagnostic applications.
Collapse
Affiliation(s)
- Steffi Lütkecosmann
- Chair of Immunotechnology, Department of Biotechnology, Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, D-14476, Potsdam, Germany
| | - Axel Warsinke
- FILT GmbH, Robert-Rössle-Str. 10, 13125 Berlin, Germany
| | | | | | - Katja Hanack
- Chair of Immunotechnology, Department of Biotechnology, Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, D-14476, Potsdam, Germany.
| |
Collapse
|
6
|
Characterizing seamless ligation cloning extract for synthetic biological applications. Anal Biochem 2016; 509:24-32. [PMID: 27311554 DOI: 10.1016/j.ab.2016.05.029] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2016] [Revised: 05/30/2016] [Accepted: 05/31/2016] [Indexed: 11/21/2022]
Abstract
Synthetic biology aims at designing and engineering organisms. The engineering process typically requires the establishment of suitable DNA constructs generated through fusion of multiple protein coding and regulatory sequences. Conventional cloning techniques, including those involving restriction enzymes and ligases, are often of limited scope, in particular when many DNA fragments must be joined or scar-free fusions are mandatory. Overlap-based-cloning methods have the potential to overcome such limitations. One such method uses seamless ligation cloning extract (SLiCE) prepared from Escherichia coli cells for straightforward and efficient in vitro fusion of DNA fragments. Here, we systematically characterized extracts prepared from the unmodified E. coli strain DH10B for SLiCE-mediated cloning and determined DNA sequence-associated parameters that affect cloning efficiency. Our data revealed the virtual absence of length restrictions for vector backbone (up to 13.5 kbp) and insert (90 bp to 1.6 kbp). Furthermore, differences in GC content in homology regions are easily tolerated and the deletion of unwanted vector sequences concomitant with targeted fragment insertion is straightforward. Thus, SLiCE represents a highly versatile DNA fusion method suitable for cloning projects in virtually all molecular and synthetic biology projects.
Collapse
|
7
|
Schmidt C, Rödiger S, Gruner M, Moncsek A, Stohwasser R, Hanack K, Schierack P, Schröder C. Multiplex localization of sequential peptide epitopes by use of a planar microbead chip. Anal Chim Acta 2016; 908:150-60. [PMID: 26826697 DOI: 10.1016/j.aca.2015.12.030] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2015] [Revised: 12/12/2015] [Accepted: 12/27/2015] [Indexed: 10/22/2022]
Abstract
Epitope mapping is crucial for the characterization of protein-specific antibodies. Commonly, small overlapping peptides are chemically synthesized and immobilized to determine the specific peptide sequence. In this study, we report the use of a fast and inexpensive planar microbead chip for epitope mapping. We developed a generic strategy for expressing recombinant peptide libraries instead of using expensive synthetic peptide libraries. A biotin moiety was introduced in vivo at a defined peptide position using biotin ligase. Peptides in crude Escherichia coli lysate were coupled onto streptavidin-coated microbeads by incubation, thereby avoiding tedious purification procedures. For read-out we used a multiplex planar microbead chip with size- and fluorescence-encoded microbead populations. For epitope mapping, up to 18 populations of peptide-loaded microbeads (at least 20 microbeads per peptide) displaying the primary sequence of a protein were analyzed simultaneously. If an epitope was recognized by an antibody, a secondary fluorescence-labeled antibody generated a signal that was quantified, and the mean value of all microbeads in the population was calculated. We mapped the epitopes for rabbit anti-PA28γ (proteasome activator 28γ) polyclonal serum, for a murine monoclonal antibody against PA28γ, and for a murine monoclonal antibody against the hamster polyoma virus major capsid protein VP1 as models. In each case, the identification of one distinct peptide sequence out of up to 18 sequences was possible. Using this approach, an epitope can be mapped multiparametrically within three weeks.
Collapse
Affiliation(s)
- Carsten Schmidt
- Brandenburg Technical University Cottbus - Senftenberg, Faculty of Natural Sciences, Großenhainer Straße 57, D-01968 Senftenberg, Germany.
| | - Stefan Rödiger
- Brandenburg Technical University Cottbus - Senftenberg, Faculty of Natural Sciences, Großenhainer Straße 57, D-01968 Senftenberg, Germany
| | - Melanie Gruner
- Brandenburg Technical University Cottbus - Senftenberg, Faculty of Natural Sciences, Großenhainer Straße 57, D-01968 Senftenberg, Germany; Department of Rheumatology and Clinical Immunology and Autoinflammatory Reference Centre at Charité, Charité-Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany
| | - Anja Moncsek
- Brandenburg Technical University Cottbus - Senftenberg, Faculty of Natural Sciences, Großenhainer Straße 57, D-01968 Senftenberg, Germany; Institute for Biochemistry, University Medicine Berlin, Charité-Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany
| | - Ralf Stohwasser
- Brandenburg Technical University Cottbus - Senftenberg, Faculty of Natural Sciences, Großenhainer Straße 57, D-01968 Senftenberg, Germany
| | - Katja Hanack
- University of Potsdam, Chair Immunotechnology, Karl-Liebknecht-Str. 24-25, D-14476 Potsdam - Golm, Germany
| | - Peter Schierack
- Brandenburg Technical University Cottbus - Senftenberg, Faculty of Natural Sciences, Großenhainer Straße 57, D-01968 Senftenberg, Germany
| | - Christian Schröder
- Brandenburg Technical University Cottbus - Senftenberg, Faculty of Natural Sciences, Großenhainer Straße 57, D-01968 Senftenberg, Germany
| |
Collapse
|
8
|
Hanack K, Messerschmidt K, Listek M. Antibodies and Selection of Monoclonal Antibodies. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2016; 917:11-22. [DOI: 10.1007/978-3-319-32805-8_2] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|
9
|
Kaba HEJ, Maier N, Schliebe-Ohler N, Mayer Y, Müller PP, van den Heuvel J, Schuchhardt J, Hanack K, Bilitewski U. Identification of whole pathogenic cells by monoclonal antibodies generated against a specific peptide from an immunogenic cell wall protein. J Microbiol Methods 2014; 108:61-9. [PMID: 25451457 DOI: 10.1016/j.mimet.2014.11.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2014] [Revised: 10/28/2014] [Accepted: 11/07/2014] [Indexed: 11/29/2022]
Abstract
We selected the immunogenic cell wall ß-(1,3)-glucosyltransferase Bgl2p from Candida albicans as a target protein for the production of antibodies. We identified a unique peptide sequence in the protein and generated monoclonal anti- C. albicans Bgl2p antibodies, which bound in particular to whole C. albicans cells.
Collapse
Affiliation(s)
- Hani E J Kaba
- Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Natalia Maier
- Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Golm, Germany
| | - Nicole Schliebe-Ohler
- Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Golm, Germany
| | - Yvonne Mayer
- MicroDiscovery GmbH, Marienburger Str., 1, 10405 Berlin, Germany
| | - Peter P Müller
- Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Joop van den Heuvel
- Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, 38124 Braunschweig, Germany
| | | | - Katja Hanack
- Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Golm, Germany
| | - Ursula Bilitewski
- Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, 38124 Braunschweig, Germany.
| |
Collapse
|